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VARIABILITY OF RADIOLOGISTS’ MAMMOGRAPHIC INTERPRETATIONS 
AND RECOMMENDATIONS FOR MANAGEMENT. Debra H. Howard, Carolyn 
K. Wells, Carol H. Lee, Alvan R. Feinstein, and Joann G. Elmore. Department 
of Internal Medicine, Yale University School of Medicine, New Haven, CT. 
Despite widespread use of mammograms as a screening tool for breast 
cancer, variability in mammogram interpretation has not been extensively 
studied. For this project, 10 radiologists were 'blinded’ to the research 
hypothesis. Using a standardized coding form, they interpreted identical sets 
of 150 mammograms, on two occasions, separated by a five month 'wash-out' 
period. There was a wide range of variability among the 10 radiologists in their 
use of diagnostic categories for the 150 patients ('normal', 16%-61%; 
'abnormal-probably benign’, 13%-47%; 'indeterminate', 8%-33%; and 
'abnormal-suspicious for cancer’, 9%-25%). The radiologists’ recommendation 
to biopsy also varied, from 9% to 31%. For diagnostic interpretations there 
was moderate agreement, with a median pairwise weighted kappa of 0.47 and 
a median weighted percent agreement of 78%. Diagnostic sensitivity ranged 
from 37% for one radiologist to 85% for another. High sensitivity values were 
often accompanied by frequent recommendations for immediate work-up in 
patients who did not have cancer. When noting the most suspicious lesion on 
a mammogram, the radiologists disagreed on side (right vs. left) in 42% of 
patients, with variability declining as interpretations became increasingly more 
suspicious. Major interpretive disagreements, in which a mammogram was 
called 'normal' by one radiologist and 'abnormal-suspicious for cancer’ by 
another, occurred in 19% of the 150 patients. Major management 
disagreements, defined as a recommendation for 'routine follow-up only’ by 
one radiologist compared to a biopsy recommendation by another, occurred in 
25% of patients. When the same set of 150 mammograms was re-interpreted 
five months later, intra-observer readings showed better consistency. Later, 
when assembled in a conference to review disagreements, the radiologists 
found that the main problems arose from differences in visual perceptions. 
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characterization of abnormalities and thresholds of concern. Active measures 
to reduce this variability are warranted and will likely necessitate extensive 
collaborative efforts for a goal of standardization coordinated with accuracy. 
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INTRODUCTION 
In the practice of medicine, results of diagnostic tests are not always 
definitive. When physicians reach different conclusions from the same 
information, the variability can lead to important clinical consequences. For 
example, in the case of blood pressure, fluctuations in measurement may 
occur. One reading may result in change in a patient’s diet, life style, and/or 
pharmacological regimen; while for the same patient, a different reading may 
mean no change at all. An evaluation of an ’acute abdomen’ may or may not 
result in surgery: and an interpretation of a mammogram may be the difference 
between inordinate anxiety and breast biopsy or calming reassurance. This 
kind of inconsistency is referred to as obsen/er variability. 
This thesis investigates observer variability in mammography. In order 
to better understand the phenomenon, this introduction will first review the 
importance of mammography in breast cancer screening and, then, observer 
variability in general. In addition, a review of previous studies of observer 
variability, specifically in mammography, will aid in placing this investigation in 
an appropriate context. 
BREAST CANCER AND MAMMOGRAPHY 
It is currently recommended by the American Cancer Society (ACS), 
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American College of Radiology (ACR), and National Cancer Institute (NCI) that 
women begin having regular mammograms every one to two years, at age 40, 
and every year after age 50 (1). These current guidelines affect millions of 
adult women annually. Current statistics show that approximately one in every 
nine women in the United States will develop breast cancer in her lifetime. It 
was projected, for 1993, that approximately 180,000 women would be 
diagnosed as having this disease and 45,000 of those women would die from it 
(2). Until breast cancer can be prevented, the most effective way for women to 
protect themselves is through early detection and prompt treatment. 
Evidence that mammography can reduce mortality from breast cancer is 
supported by several investigations (3-10). The first study to show a true 
benefit from screening for breast cancer occurred in 1963, undertaken by the 
Health Insurance Plan of New York (HIP) (9). The HIP study randomly 
assigned 62,000 women into two groups: a study group which offered 
screening on an annual basis for four years and a control group which offered 
no screening. After seven years of follow-up, the participants in the study 
group had a reduction in mortality of 23% when compared with the controls. In 
addition, this study also found that women with cancers detected by 
mammography alone had a better five year survival rate than those diagnosed 
by other modalities. The success of the HIP trial inspired the ACS and NCI to 
implement programs of mammogram screening (10). 
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There have been numerous technological advances in breast imaging 
over the past 20 years (11). In addition, since 1987, in an effort to ensure that 
current technical standards of mammography are maintained, there have been 
rigorous accreditation requirements set by the ACR (12). For example, 
equipment used for mammography at accredited sites must be designed 
specifically for mammography. Film processors must have developer time and 
temperature settings appropriate for the specific type of mammographic film 
being used. Procedure manuals and logs must be maintained in compliance 
with guidelines. Performance standards also must be monitored by 
assessments of image quality. 
There are additional requirements by the ACR for the professional 
interpreter as well. The physician must be certified in diagnostic radiology by 
the American Board of Radiology or by the American Osteopathic Board of 
Radiology, or have received two months of full-time documented formal training 
in the interpretation of mammograms. It is recommended (not required) that 
the physician interpret a minimum of 480 mammograms per year. There also 
must be participation in continuing education, specifically in mammography, 
with at least 40 hours of documented credits prior to accreditation and at least 
15 hours every three years thereafter. These requirements, however, do not 
evaluate the extent of radiologists’ variability or accuracy in interpretation. 
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OBSERVER VARIABILITY: CLINICAL MEDICINE 
The phenomenon of observer variability has been studied in many areas 
of clinical medicine (e.g., psychiatry, pathology, physical diagnosis and 
radiology) (13-14). Research in radiology, for example, has demonstrated that 
experienced radiologists can contradict each other in their interpretation of 
radiographs finter-observer variability) and the same radiologists can even be 
inconsistent in interpreting the same film twice (intra-observer variability) (IS¬ 
IS). The clinical implications of these investigations are apparent in that 
radiologists failed to identify a substantial proportion of cases with 
roentgenographic evidence of tuberculosis and frequently changed their 
readings of positive cases upon later re-reading the same films (15). Similar 
variation has been reported in the interpretation of hepatic scintigrams (17) and 
coronary angiograms (18-19). 
Observer variability has been well-researched in many radiologic 
procedures, but it has not been extensively studied in mammography, an area 
in which it could be of particular importance. In other areas of radiology, 
results are interpreted in conjunction with additional clinical and diagnostic 
information: therefore, the radiologic results often are not the sole basis for 
patient management. In mammographic screening, however, the premise is to 
detect signs of breast cancer prior to other evidence of disease (e.g., a 
palpable mass). A recommendation for biopsy may depend heavily on the 
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mammogram reading; therefore, any interpretive variability can directly affect 
the patient management plan (20). 
OBSERVER VARIABILITY: MAMMOGRAPHY 
One of the earliest investigations on observer variability in 
mammography was done in 1975. Chamberlain and colleagues studied the 
validity and observer variability of clinical examination and mammography as 
screening tests for breast cancer (21). The study enrolled 1,215 women over 
the age of 40 whose individual mammograms were read by two consultant 
radiologists. The two radiologists agreed on the need for surgical referral in 
only one-half of the patients they referred. 
In a subsequent study on xeromammograms (1982), Boyd and 
colleagues examined observer variability among nine participating radiologists 
in the Canadian National Breast Screening Study (NBSS) (20). One hundred 
xeromammograms were selected for review. Results showed that the 
radiologists varied substantially in their diagnoses. Agreement on specific 
diagnostic categories was best for the definitive diagnosis of cancer; least for 
the diagnosis of benign abnormalities; and intermediate for the diagnosis of 
normality or suspicion of cancer. Radiologists were also asked to classify films 
into one of four mammographic patterns (22), each image pattern being 
associated with varying cancer risks as developed by Wolfe (23). The 
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radiologists frequently disagreed as to whether or not a particular mammogram 
could be classified in one of the four patterns, and some radiologists did not 
classify all mammograms. Of the films which all radiologists did classify, 
however, general agreement improved. 
On review of Boyd’s study, it is noteworthy that xeromammography, a 
technical predecessor to current mammography, is rarely used today. In 
addition, two of the nine participating radiologists were each responsible for 
selecting one-half of the study films. Therefore, they were not ’blinded’ to the 
subsequent cancer outcome of each of their selected cases and their 
interpretations may have been affected. Copies rather than original films were 
used allowing for some degradation of the image quality and the possibility of 
affecting interpretation. Furthermore, any xeromammogram considered of 
inadequate quality by any one of the radiologists was excluded from the 
analysis. One radiologist designated 18 of the 100 films unsatisfactory. This 
factor reduced the data pool and may have created a bias in the remaining 
films. 
Baines and colleagues conducted a later investigation involving films 
from the Canadian National Breast Screeing Study (NBSS) (24). The NBSS, a 
randomized controlled trial (1981-1988) which recruited 89,835 women in 15 
screening centers across Canada, assessed the effect of screening on breast 
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cancer mortality. One reference radiologist was appointed to continuously 
audit the study. The random review of films by this reference radiologist was 
an attempt to monitor the quality of mammograms. Comparisons of 
interpretations between the reference radiologist and the center radiologists 
allowed for assessment of inter-observer variability; and by comparing those 
interpretations with subsequent cancer outcomes, accuracy also was assessed. 
Results showed that of 5,2CX) cases known not to have cancer, there was 
agreement in 75.8% of them. For women with screening-detected cancer (i.e., 
histologically-proven), agreement occurred in 85.6% of cases. The 
investigators concluded that for screening mammograms, there was delayed 
detection of breast cancer in 17% of cases due to observer variability and in 
5% of cases due to sub-optimal technical quality. 
Variability in mammographic interpretation was also documented in a 
study by investigators in Turin, Italy (1988) (25). Eight radiologists reviewed 45 
cases comprised of nine with histologically-proven cancer; 25 with benign 
disease, as diagnosed through fine needle aspiration; and 11 with normal 
breasts, according to two radiologists. The films used were copies obtained 
from the Canadian National Breast Screening Study. Statistical indices of 
variability between the radiologists were comparable to those reported by Boyd 
et al (20). 
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On review, the Turin investigation was a well-designed study. 
Supervising radiologists did not participate and the participants were 
representative of all but one of the local public institutions where 
mammography was performed. Radiologists were ’blinded’ to the subsequent 
cancer outcome of all cases. Study films, however, were copies taken prior to 
1985 and supplied by the NBSS. NBSS films have been criticized for their 
technical inadequacy in that time period (26). After 1985, an NBSS protocol 
change (mediolateral oblique positioning replaced straight mediolateral 
positioning) allowed for significant technical improvement (26). 
In a follow-up study by the Turin investigators, films were re-read by the 
same radiologists two years later (27). As expected, variability was higher 
among the radiologists than between two readings by the same radiologist. 
Comparisons between the two studies were diminished because the 
radiologists had been ’unblinded’ to the ’gold standard’ distribution of 
mammograms after the first study; and within the two year interim, the standard 
of recommended management had shifted from surgical biopsy to fine needle 
aspiration due to increased availability of low-cost instruments. 
GOALS OF THESIS 
The goals of this thesis are to determine whether, with the newer 
technical methods and increased utilization of mammography today, the 
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amount of variability between and among radiologists has changed. Secondly, 
this thesis investigates the variability of radiologists’ accuracy in 
mammographic interpretation and, finally, attempts to identify the sources of 
that variability. 
METHODS 
CASE SELECTION 
Mammograms for this study were selected from those done at Yale-New 
Haven Hospital (YNHH) in 1987. One hundred and fifty patients were chosen 
using a stratified random sampling technique. Cases covered a spectrum of 
three diagnostic interpretations (’normal’, ’abnormal-probably benign’, and 
’abnormal-suspicious for cancer’) which are common mammographic 
categories used in clinical practice. The mammograms also had a concomitant 
’gold standard’ designation of ’cancer’ or ’non-cancer’. The initial sampling 
year, 1987, was chosen in order to allow adequate follow-up time and to 
ensure that the designated ’gold standard’ cancer outcomes were 
representative of the true diagnoses. 
The ’gold standard’ requirements enabled the categorization of films into 
subsequent ’cancer’ and ’non-cancer’ cases. The designation of breast cancer 
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was given to a case if the diagnosis was histopathologically confirmed at 
YNHH within three years of the 1987 mammogram. A designation of ’non¬ 
cancer’ was given if the following criteria were met: the patient did not have 
histologically-confirmed breast cancer at YNHH after the 1987 mammogram 
and a diagnosis of ’normal’ or ’abnormal-probably benign’ was given to a 
follow-up mammogram taken in 1990. At the time of the follow-up 
mammogram in 1990, the patient completed a personal history form. On that 
form, a further requirement was the specification of a negative history of breast 
cancer. This ensured that the patient had not been diagnosed with cancer, in 
the interim, at a hospital other than YNHH. For example, if a patient had a 
negative biopsy which was performed as the result of the 1987 mammogram or 
within the three year interim following, she still required a ’normal’ or 
’abnormal-probably benign’ 1990 mammogram. Also, no cancer could be 
specified on the 1990 patient history form in order to be designated as ’non¬ 
cancer’ for the purposes of this study. 
Patients were ineligible for this study for the following reasons; previous 
diagnosis of breast cancer before the 1987 mammogram; no definitive 
interpretation for the 1987 film (e.g., film labeled as ’abnormal-indeterminate’ 
pending additional studies such as magnification views or ultrasound): past 
cosmetic breast surgery (reduction or augmentation); large breast size 
requiring larger film size or multiple films per view; a designated abnormality 
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visible only on lateral view; presence of a marker placed on patient’s skin; 
unavailable films; and films regarded as having inadequate technical quality. 
Some of the above criteria bear explanation. Patients with a history of 
breast cancer were ineligible because they were already on a different follow¬ 
up protocol influenced by their pathology results. By definition, they would not 
be part of a screening population and an ’inception cohort’ was desired for this 
study. Regarding patients with previous cosmetic surgery, mammograms 
should be read with full knowledge of the surgery and the patient’s clinical 
history was not provided for all cases in this study. Patients with large breast 
size were excluded because an increase in the number of study films required 
per patient would have become logistically difficult. If a critical abnormality was 
noted only on a lateral film the case was excluded because lateral views were 
not included in this study. (Only mediolateral-oblique and craniocaudal views 
were used.) The mammograms for each case were reviewed for technical 
quality by the coordinating radiologist (C. H. Lee) who was ’blinded’ to the 
patient’s identity, 1987 diagnostic interpretation, and ’gold standard’ cancer 
outcome. This quality review was implemented because mammograms with 
technical problems can obscure cancer detection (24). Once a mammogram 
was included in the study, a participating radiologist did not have the option of 
labelling a film ’technically unsatisfactory’. 
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Mammograms had been done with standard film-screen technique on a 
Thompson CGR SOOT Unit using Kodak Ortho M film and Kodak MIN-R 
screens. The original mammograms, not copies, were used in the testing to 
ensure maximum image quality. A mediolateral-oblique and craniocaudal view 
were available for each breast. To maintain confidentiality for patients, all 
mammograms were coded with numbers specific for the research. The study 
protocol was approved by the Human Investigation Committee of the Yale 
University School of Medicine. 
Cases were selected from the 4,000 mammograms taken at YNHH in 
1987. Following are definitions and an account of the randomized selection 
process for the three interpretive categories (’normal’, ’abnormal-probably 
benign’, and ’abnormal-suspicious for cancer’). 
a. ’Normal’ Category 
The definition of ’normal’ was applied to those 1987 mammograms 
which were interpreted as having no significant abnormality. This category 
included patients with fibrocystic changes and dense breasts. Mammograms 
with a recommendation for age-appropriate follow-up were included in this 
category (i.e., no other follow-up recommendation could have been made). 
Approximately 3,000 cases fulfilled this definition of ’normal’. 
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From these 3,000 ’normal’ cases, the study patients were randomly 
selected. A listing of all patients who received mammograms in 1987 were 
recorded in a record book. This record book contained 132 pages and was 
divided into two groups of 66 pages. Each page contained a maximum of 37 
lines. A random number table was used to generate three sets of numbers. 
The first set determined the group of pages from which the patient would be 
selected (odd = first group and even = second group). The second set of 
numbers delineated the page from which the patient would be selected, and 
the third set specified the page line from which the actual case was chosen. If 
the patient who met the above criteria did not have a ’normal’ mammogram 
interpretation, candidates in line order below the specified position were 
considered until one was chosen. If the end of the page was reached without 
obtaining a case, the process was repeated. 
As a list was generated, it was entered into the Yale Decrad computer 
system (Decrad) which contained a file of all radiologic procedures and 
diagnostic results at YNHH. Individuals were ineligible for this category if they 
did not have a 1990 follow-up mammogram which was interpreted as ’normal’ 
or ’abnormal-probably benign’. The patients’ medical record numbers were 
also entered into the Yale pathology computer file and were ineligible for the 
study if any history of breast cancer, prior to 1987, was indicated. 
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b. ’Abnormal-probably benign’ Category 
The definition of ’abnormai-probably benign’ applied to mammograms 
from 1987 in which findings (e.g., a mass, caicification, focai asymmetric 
density, architecturai distortion etc.) were of notable concern. Any 
mammogram with a recommendation for follow-up in less than one year was 
also included in this category. 
The Yale pathology files were used to determine if any of those patients 
had a positive biopsy for breast cancer at YNHH within three years of the 
originai mammogram. Decrad was also used to determine which patients with 
no evidence of cancer had a 1990 mammogram interpreted as ’normal’ or 
’abnormal-probably benign’. This allowed for further sub-categorization into 
’non-cancer’ and ’cancer’ patients. 
c. ’Abnormal-suspicious for cancer’ Category 
The definition of ’abnormal-suspicious for cancer’ applied to 1987 
mammograms for which a recommendation of biopsy or needle localizaton 
was made. A mammogram remained in this category even if the above- 
mentioned procedures were later deemed unnecessary. 
The Yale pathology file was used to determine biopsy resuits. A positive 
biopsy for breast cancer piaced a patient in the sub-category of ’cancer’. If a 
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patient had a negative biopsy as well as a follow-up mammogram in 1990 with 
an interpretation of ’normal’ or ’abnormal-probably benign’, she was placed in 
the sub-category of ’non-cancer’. If a patient’s 1987 mammogram was 
interpreted as ’abnormal-suspicious for cancer’ and no biopsy or needle 
localization was performed, yet the patient had a follow-up 1990 mammogram 
which was ’normal’ or ’abnormal-probably benign’, the patient was also placed 
in the category of ’non-cancer’. 
PARTICIPATING RADIOLOGISTS 
The coordinating radiologist (C.H. Lee), a specialist in mammography, 
assisted in study design and case selection. This radiologist did not participate 
as one of the ten study radiologists. Radiologists from community and 
academic practices in Connecticut and New York were invited to participate. 
Most participants were recruited through professional contact by members of 
the research team and one radiologist was contacted by a random telephone 
call through the Connecticut Yellow Pages. Requirements for participation were 
board certification in diagnostic radiology and a clinical practice that included 
reading mammograms. A distinct effort was made to select a broad spectrum 
of radiologists with regard to their experience in the interpretation of 
mammograms. The hope was that this range of experience would more 
accurately represent the reality of practicing radiologists reading 
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mammograms. 
The radiologists were ’blinded’ to the research objectives, study design, 
and number of cases in which cancer was subsequently diagnosed. Each 
radiologist received an honorarium provided by the American Cancer Society 
which was modest compensation for the total effort. 
RESEARCH DESIGN 
The research had two phases. In Phase I, the radiologists 
independently read the 150 patients’ mammograms. This was followed by a 
’wash-out’ period of five months in order to decrease the possibility that the 
radiologists might recognize the previously-read films. In Phase II, the 
radiologists re-reviewed the same 150 patients’ films. The radiologists were 
informed that male patients were excluded from the study as well as females 
with a history of previous breast cancer; but were not informed that the same 
films would be shown a second time. The radiologists had no time limit for 
reviewing the films. 
Inter-observer variability was assessed for the 150 cases in both Phase I 
and II. In both phases, 50 cases were shown with each patient’s age only, but 
no other clinical history. These were used to assess intra-observer variability. 
The remaining 100 cases in each phase were used to determine whether 
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knowledge of the patient’s clinical history affected the mammographic 
interpretation. The effects of the presence or absence of clinical histories are 
not discussed in this thesis, but will be analyzed and presented in a 
subsequent report. Of these 1CX) cases, 50 were shown with a detailed clinical 
history in Phase I and with each patient’s age only in Phase II. The sequence 
was reversed for the remaining 50 cases. 
Information on patient history was extracted from a form completed by 
each patient at the time of the 1987 mammogram and transferred to a patient 
history form used in this study (Appendix I) . The detailed clinical history 
included signs and symptoms (e.g., palpable lump, nipple discharge, skin 
change), location of previous breast biopsy, menopausal status, estrogen use, 
history of other cancers, and family history of breast cancer. In instances 
where the patient had an abnormality noted on self-examination prior to the 
1987 mammogram, the location was illustrated on the patient history form by a 
radiology technician and this was included on the history form as well. In 
Phase II, an additional five cases were shown for a third time with a deliberately 
leading ’sham’ clinical history. Again, the results of the ’sham’ history will be 
presented in a subsequent report. 
In both phases of testing, the films were arranged in a random sequence 
and numbered 1-150 and 151-305. For each mammogram, the radiologists 
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used a check-list form (Appendix III) to indicate observations, diagnostic 
interpretations and management recommendations. The check-list contents 
were based on two sources; a routine form used at YNHH for screening 
mammograms and a standardized lexicon for mammography developed and 
recommended by the American College of Radiology. Before Phase I, the 
check-list form was reviewed with the study radiologists who each received a 
brief written summary of instructions for its use (Appendix V). The radiologists 
were asked to try to simulate their own clinical practice in making diagnostic 
interpretations and follow-up recommendations. 
In descriptive observations for each mammogram, the radiologists noted 
the presence of specific abnormalities (e.g., a mass or calcification) and the 
location (right or left breast as well as a standard twelve-hour clock 
demarcation). In the presence of two or more abnormalities in the same 
patient, the radiologists were asked to note the two which were most 
suspicious. These were further delineated by noting which of those two was 
more suspicious (i.e., evoking the most concern about possible cancer). 
The diagnostic interpretations could be chosen from one of four 
categories: ’normal’, ’abnormal-probably benign’, ’abnormal-indeterminate’ 
(when the radiologist felt uncertain about the diagnosis), or ’abnormal- 
suspicious for cancer’. The radiologists were asked to avoid the category 
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’abnormal-indeterminate’ whenever possible. 
Management recommendations could be chosen from: routine 
mammographic follow-up (i.e., follow-up screening mammogram after one or 
two years according to the patient’s age); short interval mammographic follow¬ 
up (e.g., within six months): or immediate work-up (defined as additional 
mammographic views, ultrasound and/or biopsy). The radiologists were 
instructed to note at least one follow-up recommendation and they could 
recommend as many categories as were applicable. 
DATA ANALYSIS 
The original data from the patient history forms and the radiologists 
check list forms were coded numerically (Appendix II and IV), double-entered 
and verified for electronic coding. Statistical analyses were done either with 
electronic hand calculators or with programs in the EPI INFO and SAS 
statistical systems (28-29). The methods of data analysis are reviewed in the 
next four sections. 
a. Radiologists’ Observations, Interpretations and Management 
Recommendations 
The range of variability among the ten radiologists was assessed for 
observations, diagnostic interpretations and management recommendations for 
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Phases I and II. The range illustrates the lowest and highest percentage of 
times that one radiologist used a specific category (from the 150 cases) 
compared to the percentage of times that another radiologist used the same 
category. The median percentage of times that a category was noted was also 
assessed. 
b. Agreement in Diagnostic Interpretations and Recommendations 
Inter-observer agreement on diagnostic interpretations and 
recommendations for the 150 cases was calculated from the readings among 
pairs of radiologists for Phases I and II. Intra-observer variability was assessed 
for the 50 mammograms that appeared in both phases with the age of the 
patient as the only history. The statistical indices of observer variability in 
paired comparisons were percentage agreement and the kappa statistic (30). 
Both indices were weighted because not all disagreements were considered to 
be of the same magnitude. For example, a situation in which one radiologist 
diagnosed a case as being ’normal’ and another diagnosed the same case as 
’abnormal-probably benign’ was considered a less important disagreement 
than if one radiologist diagnosed ’normal’ and another, ’abnormal-suspicious 
for cancer’. By using weighted statistics, these variations in the magnitude of 
disagreement could be taken into account when determining the overall 
agreement among the radiologists. 
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An example of two radiologists’ diagnostic interpretations for the same 
150 patients is shown in Table I. This can serve as an example of the 
appraisal of painvise comparisons of interpretations by two radiologists. The 
numbers on the shaded diagonal Indicate interpretive agreement between 
Radiologist A and Radiologist B. The two radiologists agreed on the 
interpretation of ’normal’ in 34 of the 150 patients and, at the other extreme, on 
the interpretation of ’abnormal-suspicious for cancer’ in 15 patients. The two 
radiologists did not agree on the mammograms outside of the shaded 
diagonal. For example, when Radiologist A interpreted ’normal’ in 64 patients. 
Radiologist B agreed in only 34, interpreting 18 of those ’abnormal-probably 
benign’, 10 ’abnormal-indeterminate’, and 2 as ’abnormal-suspicious for 
cancer’. 
Percentage agreement is calculated by adding the total number of cases 
which lie on the shaded diagonal (indicating perfect agreement) and, then, 
dividing this sum by the total number of cases. Thus, the percentage of 
perfect agreement in this example is [(34-j-lO-i-12-1-15/150]x100=47%. 
However, to allow for differences in the degree of importance of 
disagreements, a weighted calculation is used. The weighted agreement is 
calculated by multiplying the number in each cell by a specified weight (i.e., 1, 
0.66, 0.33, or 0 ) (28) and adding all the products. This sum is divided by the 
total number of cases. Thus, weighted agreement for Table 1 is 
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[{[(34+10+12+15)x1] + [(18+23+6+3+6+4)x0.66] + [(10+1+H-5)x0.33] + [(2+ 
0)x0]}/150]x100=78%. 
Some agreement of interpretations of mammograms can be expected by 
chance alone. The kappa statistic corrects the amount of agreement observed 
for the agreement that is expected by chance. The formula for weighted kappa 
is: 
= PO^ - PC^/1 - PC^ 
where PO^ is the proportion of weighted agreement (calculation shown above) 
and PC^ is the proportion of weighted agreement expected by chance. To 
calculate a weighted kappa statistic, this weighted agreement expected by 
chance must be derived. This is calculated by multiplying the row totals 
(Radiologist A’s interpretations) by the column totals (Radiologist B’s 
interpretations) and dividing by the total number of cases. This gives a 
calculated value for each cell. This value is then multiplied by a cell weight, the 
products added, and that sum divided by the total number of cases. For Table 
1, the percent weighted agreement expected by chance is 59.5%. For the 
example shown in Table 1, kappa value is = 0.78 - 0.595 / 1- 0.595 = 0.46. 
To interpret the weighted kappa statistic, a score of 1.0 indicates perfect 
agreement and a score of < 0.0 indicates agreement which is no better than 
expected by chance. Landis and Koch have suggested the following ratings of 
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agreement for values of kappa: <0, poor; 0 - .2, slight; .21 - .40, fair; .41 - .60, 
moderate; .61 - .80, substantial; and .81 -1.00, almost perfect (31). 
c. Accuracy 
The radiologists’ accuracy (sensitivity and specificity) for the diagnosis 
of cancer was determined for the category ’abnormal-suspicious for cancer’ vs. 
a combination of all other diagnostic categories (’normal’, ’abnormal-probably 
benign’, and ’abnormal-indeterminate’). The percentage of patients for whom 
each radiologist recommended immediate work-up, defined as a 
recommendation for additional mammogram views, ultrasound, and/or biopsy, 
was evaluated for both the ’cancer’ and the ’non-cancer’ patients. 
Specific attributes of the participants were correlated with accuracy to 
determine if any relationship existed. Attributes examined include: clinical 
practice type (academic vs. private); years of radiologic experience; percent of 
time spent reading mammograms; and whether or not the participant 
considered him/herself an ’expert’ in mammography. The statistical index used 
was the Pearson correlation coefficient (28). 
d. Major Disagreements in Locations of Abnormaiities, 
Interpretations, and Recommendations 
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For any pair of two radiologists reading the same patient’s mammogram, 
major disagreements were defined as follows: 
1) Location of abnormalities: The most significant abnormal lesion was 
said to be located in the right breast by one radiologist and in the left breast by 
another. A citation of ’bilateral’ by one radiologist and a ’specific side’ by 
another radiologist was not counted as a disagreement. Cases in which only 
one radiologist noted a lesion were excluded from this tabulation. 
2) Diagnostic interpretations: The same patient’s films were called 
’normal’ by one radiologist and ’abnormal-suspicious for cancer’ by another. 
3) Management recommendations: For the same patient, routine 
mammographic follow-up was proposed by one radiologist and biopsy by 
another. 
The proportions of major clinical disagreements were calculated in two 
ways: first, for their occurrence within the 150 patients (per-patient 
comparison); and second, for their occurrence within the maximum number of 
pairwise comparisons (per-pain/vise comparison). 
For the per-patient calculations, the numerator was the number of 
patients in whom at least two radiologists had a major disagreement in location 
of abnormality, diagnostic interpretation or management recommendation. The 
denominator for these calculations was 150 patients for the diagnostic 
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interpretations and management recommendations. For calculations of 
disagreement in the location of abnormalities, the denominators varied since 
abnormalities were not noted in all mammograms. The denominators for these 
calculations were the number of patients (or painvise comparisons) in whom at 
least two radiologists had noted an abnormality. The percentage of patients 
for whom disagreements in location of abnormalities occurred, was calculated 
when: a) any abnormality was noted, b) an immediate work-up was 
recommended, and 3) a biopsy was recommended. 
For the per-painvise calculation, the numerator is the number of pairwise 
disagreements noted and the denominator is the maximum number of possible 
pairwise comparisons. The maximum number of pain/vise comparisons for 10 
radiologists is 45 (= 10 x 9/2) pairs for an individual patient, and 6,750 (= 45 x 
150) pairs for the entire series of 150 patients. 
ASSESSMENT OF SOURCES OF VARIABILITY 
After the Phase II testing, and with preliminary results available for the 
Phase I analysis, the participating radiologists were assembled for a 
conference at which they were ’unblinded’ to the study goals and research 
design. Preliminary data from Phase I was presented. Six cases were 
reviewed which were representative of great variability in interpretation. The 
radiologists received copies of their personal check-list forms for the cases 
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discussed. The goal of the discussion was to identify causes of the variability 
which had been noted and to understand better at what level the variability was 
occurring. 
RESULTS 
SELECTION OF CASES 
Cases were selected from the 4,000 mammograms taken at YNHH in 
1987 which had been interpreted as ’normal’, ’abnormal-probably benign’ and 
’abnormal-suspicious for cancer’. Each of the three categories was partitioned 
further into ’cancer’ and ’non-cancer’ outcomes based on the ’gold standard’ 
definition. Originally, a goal of 50 mammograms in each of the three 
interpretive categories was desired. In addition, it was hoped that 
approximately one-half of the ’abnormal - probably benign’ category and one- 
half of the ’abnormal - suspicious for cancer’ category would be ’cancer’ cases 
This would have allowed for assessment of variability in the more complicated 
cases while trying to adhere to percentages seen in clinical practice. Because 
of eligibility and exclusion criteria, especially in the ’abnormal - suspicious for 
cancer’ category, the final study population was different than predicted. The 
following three paragraphs are an account of the results of the selection 
process for each of the three diagnostic categories. 
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There were approximately 3,000 mammogram cases interpreted as 
’normal’ in 1987 at YNHH of which 275 cases were randomly selected for this 
study. Of those 275 cases, 89 had appropriate 1990 follow-up (i.e., a 
mammogram Interpreted as ’normal’ or ’abnormal-probably benign’) and of 
those 89 cases, 36 did not meet other eligibility criteria (Table 2). One patient 
with a ’normal’ 1987 mammogram which was randomized into the group of 275 
cases was found to have subsequent breast cancer within three years of the 
original mammogram. A final group of 54 ’normal’ category patients (one with 
subsequent breast cancer) completed this category. 
Criteria for the category ’abnormal-probably benign’ applied to 567 
patients in 1987. Subsequent breast cancer was found in 17 patients, 10 of 
whom did not meet eligibility criteria. Of the 550 remaining ’abnormal-probably 
benign’ category cases, 190 had appropriate follow-up and 93 were chosen 
randomly. Of those 93, eligibility criteria were not met by 39. A final group of 
61 patients (seven with subsequent breast cancer) comprised the ’abnormal- 
probably benign’ category. 
The criteria for the category ’abnormal-suspicious for cancer* applied to 
124 patients in 1987. Biopsy-proven breast cancer was found in 43 patients 
(before 1990) and 24 of these cases did not meet eligibility criteria. Of the 
remaining 81 ’abnormal-suspicious for cancer’ category patients who did not 
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have histologically-confirmed cancer at YNHH, 29 had appropriate 1990 follow¬ 
up. Eligibility criteria were not met by 13 patients. A final group of 16 patients 
was obtained bringing the ’abnormal-suspicious for cancer’ category to a total 
of 35 cases (19 ’cancer’ patients). 
In summary, within the final study population of 150 patients, the 
diagnostic interpretations from 1987 (and subsequent breast cancer status) 
were as follows: 54 ’normal’ (1 ’cancer’ patient): 61 ’abnormal-probably 
benign’ (7 ’cancer’ patients); and 35 ’abnormal-suspicious for cancer’ (19 
’cancer’ patients). 
The 150 patients included 95 (63%) who were at least 50 years of age 
(range of 33 - 83 years) (Table 3). Twenty-two (15%) patients were 
symptomatic (e.g., noted a lump or nipple discharge) and 40 (27%) had a past 
benign breast biopsy. Forty-four (29%) patients had a relative with breast 
cancer. Breast cancer was diagnosed within three years after the 1987 
mammogram in 27 (18%) patients; and of those 27 patients, 22 were 
diagnosed within the first year. 
Of the 27 study patients diagnosed with breast cancer, many histological 
types were represented. Twenty-three patients had ductal carcinoma 
(intraductal, 6; infiltrating, 7; intraductal/infiltrating, 1; mucinous, 1; papillary, 1; 
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and intraductal/papillary, 1). Lobular carcinoma was diagnosed in three 
patients (infiltrating, 2; infiltrating/in situ, 1). Combined ductal and lobular 
carcinoma was seen in one patient. 
PARTICIPATING RADIOLOGISTS 
Of the ten radiologists who participated in this study (Table 4), seven 
were in private practice in New York or Connecticut and three held full-time 
academic positions. A total of 15 radiologists, known to members of the 
research team through previous professional associations, were contacted. Of 
these, nine agreed to participate in the study. One participant was contacted, 
on the first attempt, through a random telephone call using the New Haven 
Yellow Pages. The group’s clinical experience, defined as the number of years 
in practice, had a median of 12 years (range, 5 -30) and the group had a 
median of 3.5 years (range, 1.5 - 20) of specific experience in reading 
mammogi'ams. The median estimated number of mammograms interpreted in 
the year before the study was 1900 (range, 200 - 6,000); and the median 
percentage of time spent reading mammograms in clinical practice was 25% 
(range, 8% - 50%). 
After Phase II of the study but prior to being ’unblinded’, a telephone 
survey of the participants was conducted to gain additional information 
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(Appendix VI). Without defining the term ’expert’, in the telephone survey, 
three radiologists considered themselves an ’expert’ in mammography. Seven 
radiologists said they were not aware that the same mammograms had been 
shown in Phases I and II. Of the remaining three radiologists, two said that 
they recognized less than 3% of the mammograms in Phase II and one 
claimed to have recognized about 25%. When asked if they had given the 
study mammograms the same consideration as in their clinical practices, seven 
answered "yes"; two answered "I tried"; and one replied "no" (implying that less 
consideration was given the study films than in his/her clinical practice). 
Although this radiologist answered "no", results of sensitivity and specificity for 
this radiologist were on par with the other nine participants. When the 
radiologists were asked in what percentage of mammogram cases they 
thought variability became clinically important, responses ranged from 1% to 
40% with a median of 15%. 
OBSERVER VARIABILITY 
a. Radiologists’ Observations, Interpretations and Management 
Recommendations 
The median and range of the percentage of patients in whom the 
radiologists noted the indicated observations, diagnostic interpretations and 
management recommendations varied among the 10 radiologists (Tables 5,6). 
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For example, in Phase 1 (Table 5) among the 150 patients, the median percent 
of patients with a mass noted was 26%. The range for the 10 radiologists was 
quite wide, with a mass being noted in only 19% of the cases by one 
radiologist and, at the other extreme, in 40% by another. The use of the 
diagnostic interpretation of ’normal’ had a median of 31% with a range of 16% - 
61%. For management recommendations in Phase I, one radiologist 
recommended routine mammographic follow-up in only 22% of the cases 
compared with 71% by another, and the recommendation for biopsy ranged 
from a low of 9% to a high of 31%. Phase II results were similar (Table 6). It 
should be noted that these percentages do not necessarily refer to the same 
patients. For example, two radiologists may have recommended a biopsy in 
20% of patients, but this did not mean that the biopsy recommendations were 
necessarily made on the same patients. 
b. Agreement on Diagnostic Interpretations and Recommendations 
All 10 radiologists agreed on a patient’s specific diagnostic interpretation 
in only nine (6%) cases. These nine cases were interpreted by all 10 
radiologists as either ’normal’ or ’abnormal-suspicious for cancer’. At least five 
of the 10 radiologists agreed in 121 (87%) cases. In most of these cases, the 
interpretations were also ’normal’ or ’abnormal-suspicious for cancer’. 
The agreement among the 10 radiologists on diagnostic interpretation 
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and biopsy recommendations was assessed (Tables 7,8). The statistical 
indices of concordance were weighted for the four ordinal interpretive 
categories, but not for the binary (yes/no) biopsy categories. For Phase I 
(Table 7), the median percentage agreement was 78% (range, 71% - 82%) for 
inter-observer variability in interpretations, and 85% (range, 65% - 91%) for 
recommendations to biopsy. The corresponding median kappa values were 
0.47 (range, 0.31 - 0.55) for diagnostic interpretations and 0.49 (range, 0.20 - 
0.69) for biopsy recommendations. Landis and Koch (31) would assign these 
kappa values a rating of ’moderate’ agreement. Phase II results were 
essentially similar (Table 8). The corresponding results were higher for intra¬ 
observer than for inter-observer agreement. 
c. Accuracy 
There was considerable variability in accuracy among the 10 radiologists 
in diagnosing the 27 patients with ’cancer’ (Table 9). For Phase I, 
interpretations ranged from Radiologist A, who called 23/27 patients ’abnormal- 
suspicious for cancer’ and none ’normal’, to Radiologist J who called only 
10/27 patients ’abnormal-suspicious for cancer’ and interpreted six as ’normal’. 
Sensitivity for diagnosing cancer was highest (85%) for Radiologist A 
and lowest (37%) for Radiologist J (Table 10). The values of sensitivity 
generally declined as specificity rose. This inverse relationship was most 
evident in the recommendations for immediate work-up (Table 10). This trend 
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was also seen in Phase II analysis (Table 11). 
An analysis was performed in order to examine any significant 
correlation between specific physician attributes and accuracy (sensitivity and 
specificity) of interpretation. Attributes examined were clinical practice 
(academic vs. private), years of radiologic experience (since completion of 
residency training), percent time spent reading mammograms (in the year prior 
to this study), and whether or not the participant considered him/herself an 
’expert’ in mammography. No significant correlation was found for any of the 
above. There was a promising correlation between the percent time spent 
reading mammograms and interpretive sensitivity (i.e., the more time a 
radiologist spent reading mammograms, the higher his/her sensitivity/specificity 
values). However, since only 10 radiologists were studied, it was not 
statistically significant (r = 0.09, 0.33). 
d. Disagreements in Locations of Abnormalities 
When two or more radiologists noted an abnormality, disagreement on side 
(right vs. left) occurred in 42% of per patient comparisons and 12% of per 
pairwise comparisons for Phase I (Table 12). In cases where immediate work¬ 
up was recommended, disagreement on the side of the abnormality occurred 
in 33% of patients and 9% of pairwise comparisons. There was disagreement 
in biopsy recommendations, as to right or left side, in 9% of patients and in 2% 
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of pairwise comparisons. For example, there was more agreement on which 
side to biopsy than which side required immediate work-up. Although this 
variability was considerable, it declined as interpretations became increasingly 
more suspicious. Phase II results are similar (Table 13). Surprisingly, intra¬ 
observer analysis (the frequency with which a radiologist disagreed with his/her 
own specification of the side with the most significant abnormality) showed 
disagreement in 14% of patients and in 3% of per pairwise comparisons for 
recommendations for biopsy. These values are actually higher than the inter¬ 
observer calculations. 
e. Major Disagreements in Interpretations and Recommendations 
In Phase I, of the 150 patients receiving readings from 10 radiologists, a 
major interpretive disagreement occurred in 19% of patients and 2% of the 
pairwise comparisons (Table 14). Major management disagreements occurred 
in 25% of patients and 3% of the pain/vise comparisons. Once again, the intra¬ 
observer comparisons showed better agreement. Phase II results are similar 
(Table 15). 
EXPLANATIONS FOR VARIABILITY 
At the conclusion of Phase II testing, a conference attended by eight of 
the ten participating radiologists was convened. Participants were ’unblinded’ 
to the study goals and research design. Data from Phase I was also 
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presented. Six mammograms which showed considerable variability in 
interpretation were reviewed. The conference was tape-recorded and a 
verbatim manuscript was produced (Appendix VII). The following excerpts 
illustrate the discussion of one case. The radiologists are listed by number in 
the order in which comments were made.. 
The 10 radiologists’ ranges of diagnostic interpretations and 
management recommendations for this case (subsequently found to be ’non¬ 
cancer’) were; 
INTERPRETATIONS_# RADIOLOGISTS 
Normal 3 
Abnormal-probably benign 1 
Indeterminate 4 
Abnormal-suspicious for cancer 2 
MANAGEMENT 
RECOMMENDATIONS_# RADIOLOGISTS 
Age-appropriate follow-up 3 
Repeat mammogram<. 6 months 1 
Additional x-ray views now 1 
Ultrasound 0 
Biopsy 2 
Radiologist #1: "What bothered my eye was the asymmetry in the 
periareola area....The thickening in the left nipple caught my eye...when I look 
at a mammogram, I look for some degree of symmetry...! was worried...! read it 
as malignant. I thought it was Paget’s, frankly...! didn’t see anything in the 
right breast that bothered me. I thought there were benign calcifications." 
Radiologist #6: "I agree." (calcifications) 
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Radiologist #2: "I called this normal and I was fairly shocked because 
when you put the film up, I said, ’look at that’...I didn’t see it...This is the thing 
that you hope doesn’t happen to you in your practice." 
Radiologist #3: "There is some range of asymmetry that is 
tolerable...This passes my threshold for asymmetry." 
Radiologist #4: "I made no comment about that (asymmetry). I dwelled 
on the calcifications. Elsewhere in the breast I would consider that significant 
(asymmetry), but the areola is the one area where there can be both much more 
thickening and asymmetry...If you think that is abnormal, then I don’t think I 
would follow it...you’d either call it normal or punch biopsy the skin. Those are 
the only choices." 
Radiologist #5: "I thought some of these were irregular (calcifications)...\ 
was worried about them"....(Larer) "It’s a few of them, it’s not all of them...I don’t 
know how many you have to have before you worry about them. I wouldn’t 
call these benign, I know that." 
Discussion Leader #1: "If I said, O.K., picture this...calcifications that are 
branching, irregularly shaped, everybody would agree that those are 
suspicious. The question is when you look at this, some people come up with, 
’these fit those criteria and therefore are suspicious’ and others say, ’these do 
not fit those criteria and therefore are not suspicious.’" 
Radiologist #7: "....there was certainly asymmetry between the 
appearance of both breasts, and the periareola skin thickening in the left breast 
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was worrisome, but ’indeterminate’ in my eyes....I wanted more films...and plus 
bring her back in 3 months." 
Upon careful review of the conference, three main sources of variability 
were identified. The first was differences in visual perception. Not surprisingly, 
subtle findings were sometimes missed (as in the above example by 
Radiologist 2). In other instances, some radiologists noted masses where 
others saw only normal parenchyma. 
A second source of variability arose from different perceptions about 
attributes of the same abnormality (as illustrated by the comments of 
Discussion Leader #1). Although agreeing that the mammogram showed 
calcifications and also agreeing on the criteria for ’benign’ and ’suspicious’ 
calcifications, there was still disagreement as to whether the calcifications in 
question fit ’benign’ or ’suspicious’ criteria. 
The third main source of variability was different thresholds of concern 
about perceived abnormalities correlating to variability in management 
recommendations. For example. Radiologist #1 was "worried" by the 
asymmetry which (s)he noted in the periareola area and felt that it was 
malignant. Radiologist #4, while agreeing that there was nipple asymmetry, 
was not concerned by it, feeling that the areola is one area where thickening 
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and asymmetry can be tolerated. 
A feeling of great interest and spirited cooperation pervaded the 
conference. Results of the discussions indicated that at least part of this 
variability may be reducible. This would require improvement of diagnostic 
criteria and thresholds of concern through extensive collaborative effort. The 
evening concluded with a presentation of certificates of appreciation to each 
radiologist for his/her support and assistance in this thesis project (Appendix 
VIII). 
DISCUSSION 
This investigation found substantial variability among 10 radiologists in 
mammographic diagnostic interpretations, management recommendations and 
clinical accuracy. The design of this study attempted to avoid the problems of 
previous studies of observer variability. The films used in the study employed 
relatively current techniques of mammographic imaging. Although there have 
been great advances in breast imaging over the past twenty years, there have 
been no major developments since 1987, the year from which the study 
mammograms were taken. The participating radiologists read original, not 
duplicate, films; therefore the concern about image degradation was negated. 
Following the random selection of films, the coordinating mammographer (in a 
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’blinded’ review) screened all mammograms to eliminate those of inadequate 
technical quality. This minimized the risk of cancer detection being obscured. 
The participants were ’blinded’ to research goals and study design. 
They were also unaware of the diagnostic distribution of the films and 
subsequent outcome of each patient’s status for breast cancer. However, one 
radiologist claimed to recognize approximately 25% of study cases from 
previous clinical experience at YNHH. Nevertheless, the considerable degree 
of variability found in the diagnostic interpretations and management 
recommendations are similar to the findings of previous studies (20-22, 24-27) 
(Table 16). 
Careful attention was paid to the selection of the participating 
radiologists. Radiologists were sought who were currently reading 
mammograms in their clinical practices, yet had varied experience in 
mammography. This was an attempt to represent more accurately the 
professional community currently reading mammograms. Also, the differences 
in experience among the radiologists could be analyzed to see if a correlation 
with accuracy existed. Even though there were ten radiologists, too small a 
group to test statistical significance, the group was not too small to note 
trends and a trend was noted in the percent time spent reading mammograms 
and sensitivity/specificity values. 
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One of the most interesting challenges of this project was the decision 
concerning methods for analyzing results of disagreement. Analysis was 
conducted by two methods: per patient and per pairwise comparisons. 
Together, these calculations probably present the best overall sense of the 
boundaries of the disagreement. In the per patient comparisons, the variability 
may have been over-estimated as comparisons were dependent on the 
number of participating radiologists. For example, a major disagreement 
occurred if any t^ of the radiologists disagreed. It was possible for nine 
radiologists to be in total agreement, but one dissenting radiologist could 
cause a particular case to be categorized as a major disagreement. Clearly, 
the greater the number of participating radiologists, the greater the chance of 
major disagreement and variability. On review of this analysis, no one 
radiologist was consistently a minority dissenter. In other words, there was no 
’oddball’ reader. In the per pairwise comparisons, variability could have been 
under-estimated. The per pairwise disagreements were determined with a 
denominator (45 x 150 = 6,750) which is the maximum number of pairwise 
agreements. This number was used as it is logical and easy to explain; 
however, it is actually twice the number of possible pairwise disagreements 
which is 3,750 (25 x 150). Therefore, the presented numbers for per pairwise 
comparisons are actually one-half of what they should be for a true value. For 
example, major disagreements in interpretations occurred in 4% of the per 
pairwise comparisons as opposed to 2% previously stated. 
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Another reason for the possible underestimation of variability is that 
when observations, diagnostic interpretations and management 
recommendations were compared among radiologists (Tables 5,6), there were 
no means to confirm that they were indeed referring to the same abnormality 
on the same patient’s film. For example, two or more radiologists may have 
noted a mass in 30% of patients, but the lesion of concern may have been in 
different breasts. Even if two or more radiologists recommended biopsy of the 
same breast in the same patient, there could have been disagreement as to 
the specific location of the lesion in question (i.e., one could be commenting 
on a lesion at one o’clock and the other, a lesion at seven o’clock.) 
The category of ’abnormal-indeterminate’ presented a challenge as to 
where and how it should be included in the analysis. A decision was made to 
maintain those films within the study so as not to reduce the data pool and 
cause possible bias. Eliminating those films interpreted as ’abnormal- 
indeterminate’ could have led to greater agreement as evidenced by increased 
kappa values. For example, if mammograms interpreted as ’abnormal- 
indeterminate’ were excluded, the kappa value of Radiologists A and B (Table 
I) would increase from 0.46 to 0.59. In the determination of sensitivity and 
specificity, if the diagnostic categories were partitioned into a combination of 
’abnormal-suspicious for cancer’ and ’abnormal-indeterminate’ vs. ’abnormal- 
probably benign’ and ’normal’, there may have been a trend toward increased 
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sensitivity at the expense of decreased specificity (e.g., sensitivity for 
Radiologist A, as shown in Table 10, would increase from 85% to 89%, but 
specificity would decrease from 93% to 70%). 
INVESTIGATIVE CONSIDERATIONS 
No research can perfectly mimic the ’real world’ and this study, too, 
must be viewed with considerations. Although ’blinded’ to research goals, and 
asked to simulate their own clinical practices, the participants in this study were 
still aware that they were in a ’test’ situation. On the one hand, this may have 
produced a sense of ’over-reading’, resulting in abnormalities noted and work¬ 
ups recommended which may have been dismissed in daily clinical practice. 
On the other hand, knowledge that the study interpretations were not directly 
related to individual patient care may have created less concern and resulted in 
’under-reading’. 
In this test situation, the radiologists did not have access to previous 
mammograms for comparison or, in some situations, a complete patient 
history. They were also limited to two views per breast per patient. Access to 
this information may have made a difference in results of variability and 
accuracy. The results of an immediate work-up recommendation (ultrasound, 
magnification views, etc.) was also not available. If these results had been 
yJMJWWW 
».' Wfittl , .-i , A 7-®j[Qo4o4b®f? 
■rri i„ -., • .5...>.3t> bluc^ ^)io*q0 
i A«>4TII3Vltl 
' - f •''» ; .. r-ttiw/ ad taufri 
■ *1 ' ; '• ^'■:- «*»rft -^tsiumik bf»ji«6 
I. H « / o%-k ytHlJ tHrlt •taVVA tti/9 
. *■ - MA c, To r.^r^e « r^iwuboiq 
, * . .-1 :'* j4rf.,y i'jc’D<u*jiT»mooai t<4u 
v.u !*»•,•'/( »drf*0 ^ nO 
...■•I* v^"f ’ , <tjO*»c- fi t'iyu.vti oJ ■* 
• \ .i ~* nl 
I n -omfrikirt 
"a ?4* » *v‘* tos«1iH^ It 
, f '. I:v I'.u' 
IfUl ^i‘tldi-1 t.:' 
noBiiHroini mm 
■f (I v I r_, 
'i/ iwj ici 
(MtaO l**J' 1 J .■■ ;7'] ', 
'-•;U.j(nv6 Jen Oit* ktm {.atk 
-'(^*neAfn 
43 
immediately available, for example, an ’abnormal-indeterminate’ study 
mammogram may have been changed to an ’abnormal-probably benign’ or 
’abnormal-suspicious for cancer’ category. 
In introductory guidelines before Phase I, the participants were asked to 
limit the use of the ’abnormal-indeterminate’ category whenever possible. 
There was an awareness that too many ’abnormal-indeterminate’ interpretations 
might yield inconclusive results. Some radiologists adhered to this guideline 
more than others. This request may have forced a premature categorization of 
mammograms in some cases. At the outset, one radiologist felt 
"uncomfortable" in limiting the use of this category and, subsequently, used it 
quite often. 
The study population was ’enriched’ with difficult cases in the sense that 
there were more diagnoses of ’abnormal-probably benign’ and ’abnormal- 
suspicious for cancer’ (which subsequently proved to have breast cancer). 
This spectrum of patients might not be found in a random collection of 150 
cases of asymptomatic screening mammograms. If the spectrum of study 
mammograms had reflected the proportions encountered in actual practice, 
there would have been too few cases to provide any challenges for the 
radiologists and disagreement may have been diluted. Agreement would have 
likely increased as would be reflected by higher kappa values and weighted 
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percent agreements. 
CONCLUSIONS 
The American College of Radiology is working toward improving 
standards of mammography. An accreditation program begun in 1987 has 
specific criteria which encompass both technical performance and professional 
practice. This accreditation program serves as the only standardized basis for 
quality assurance. However, this program does not address the variability 
among individual readers of mammograms. In an indirect way, the 
development of an ACR lexicon was an attempt to standardize readings of 
mammograms. In the analysis of this study and in discussion with the 
radiologists who attended our conference, it became apparent that vocabulary 
alone would not solve the problem of variability. Even when the radiologists 
agreed on nomenclature, they had varying levels of disagreement as to 
whether the nomenclature applied to a specific visual perception. There was 
additional variability in thresholds of concern provoked by the nomenclature. 
Finally, even when there was agreement as to both observations and 
nomenclature, there were still varied management recommendations. For 
these reasons, it is apparent that further steps are needed to reduce observer 
variability in mammography. Standardization coordinated with accuracy (not 
standardization for its own sake) should be an important goal. 
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The results of this thesis show that radiologists can and do vary, 
sometimes substantially, in their observations, diagnostic interpretations and 
management recommendations for mammograms. To reduce this variability, 
more active steps will be needed than development of nomenclature and 
dissemination of information regarding visual criteria. Within this project, 
further study is ongoing to dissect the radiologists’ variability in visual 
perceptions, perceptual designations and threshholds of concern. It is hoped 
that very specific causes of this variability will be identified e.g., different breast 
parenchymal densities and use of specific terminology. Collaborative efforts 
among radiologists also will be required to examine actual performance and to 
reduce variability while preserving accuracy. In addition, self-auditing 
procedures by individual radiologists, specialized education and perhaps even 
specialized accreditation should be considered. Given that millions of women 
each year are recommended for mammography and its acceptance as a 
screening tool is continuously increasing, it is of great importance to actively 
focus on the reduction of observer variability. 
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TABLE 1. EXAMPLE OF PAIRWISE COMPARISON OF DIAGNOSTIC 
INTERPRETATIONS BY TWO RADIOLOGISTS. 
RADIOLOGIST ^B^ 
Abnormal- Abnormal- Abnormal- 
Probably Indeter- Suspicious 
Normal Benign minate for Cancer TOTAL 
Summary Measures of Agreement Between Radiologist 'A' & 'B': 
% Weighted Agreement = 78% 
Weighted Kappa = 0.46 
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TABLE 3. CHARACTERISTICS OF THE 150 STUDY PATIENTS. 
No. PTS. 
AGE > 50 YEARS. 95 (63%) 
POST-MENOPAUSE. 84 (56%) 
SYMPTOMATIC 
(e.g., breast lump). 22 (15%) 
PAST BREAST BIOPSY. 40 (27%) 
RELATIVE WITH BREAST CANCER.. 44 (29%) 
PREVIOUS HISTORY OF CANCER... 15 (10%) 
CURRENT ESTROGEN USE. 37 (25%) 
BREAST CANCER DIAGNOSED 
WITHIN 3 YEARS AFTER MMG. 27 (18%) 
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TABLE 4. CHARACTERISTICS OF THE 10 PARTICIPATING 
RADIOLOGISTS. 
PRACTICE TYPE: 3 Private, 
CLINICAL EXPERIENCE 
7 Academic 
MEDIAN 
(CT & NY) 
RANGE 
No. Years practice: 12 5-30 
Estimated No. Mammograms 
read(1991): 1,900 200-6,000 
Estimated % time reading 
Mammoarams in oractice: 23% 8%-50% 
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TABLE 5. MEDIAN AND RANGE FOR PERCENT OF PATIENTS 
IN WHOM 10 RADIOLOGISTS NOTED THE CITED OBSERVATION, 
DIAGNOSTIC INTERPRETATION, AND RECOMMENDATION (PHASE I). 
% of patients for whom 
this result was reported 
Median Ranae 
OBSERVATION 
Mass 26 19-40 
Focal Asymetric Density 16 8-35 
Calcification 25 16-33 
DIAGNOSTIC INTERPRETATION 
Normal 31 16-61 
Abnormal-Probably Benign 25 13-46 
Abnormal-Indeterminate 19 8-33 
Abnormal-Suspicious 
for Cancer 18 9-25 
RECOMMENDATION 
Routine Follow-up Mammogram 28 21-73 
Repeat Mammogram < 6 Months 12 5-36 
Immediate Follow-up 
-Additional Mammogram Views 37 11-57 
-Ultrasound 10 5-23 
-Biopsy 18 9-31 
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TABLE 6. MEDIAN AND RANGE FOR PERCENT OF PATIENTS 
IN WHOM 10 RADIOLOGISTS NOTED THE CITED OBSERVATION, 
DIAGNOSTIC INTERPRETATION, AND RECOMMENDATION (PHASE II). 
% of patients for whom 
this result was reported. 
Median Ranae 
OBSERVATION 
Mass 29 19-33 
Focal Asymetric Density 19 6-46 
Calcification 24 19-36 
DIAGNOSTIC INTERPRETATION 
Normal 30 15-61 
Abnormal-Probably Benign 23 7-47 
Abnormal-Indeterminate 21 12-39 
Abnormal-Suspicious 
for Cancer 18 6-31 
RECOMMENDATION 
Routine Follow-up Mammogram 31 11-77 
Repeat Mammogram < 6 Months 14 0-13 
Immediate Follow-up 
-Additional Mammographic Views 38 11-71 
-Ultrasound 10 6-23 
-Biopsy 20 10-34 
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TABLE 7. AGREEMENT ON DIAGNOSTIC INTERPRETATIONS AND BIOPSY 
RECOMMENDATIONS (PHASE I) . 
INTER-OBSERVER 
VARIABILITY 
(N=150 patients) 
Median franae^ 
INTRA-OBSERVER 
VARIABILITY 
(N=50 patients)^ 
for 10 Radioloaists 
Phase I Phase I vs II 
Reading 
DIAGNOSTIC 
INTERPRETATION 
% Weighted 78% 84% 
Agreement (71%-82%) (72%-89%) 
Weighted 0.47 0.57 
Kappa (0.31-0.55) (0.37-0.71) 
BIOPSY 
% Agreement 85% 91% 
(65%-91%) (82%-98%) 
Kappa 0.49 0.71 
(0.20-0.69) (0.46-0.91) 
’ In Phase II, one radiologist did not give a diagnostic 
interpretation for one case. 
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TABLE 8. AGREEMENT ON DIAGNOSTIC INTERPRETATIONS AND BIOPSY 
RECOMMENDATIONS (PHASE II) . 
INTER-OBSERVER 
VARIABILITY 
(N=150 patients)^ 
Median franae^ for 10 Radioloaists 
Phase II 
DIAGNOSTIC 
INTERPRETATION 
% Weighted 77% 
Agreement (65%-82%) 
Weighted 0.41 
Kappa (0.24-0.58) 
BIOPSY 
% Agreement 83% 
(73%-95%) 
Kappa 0.49 
(0.28-0.80) 
^In Phase II, one radiologist did not give a diagnostic 
interpretation for one case. 
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TABLE 9. ACCURACY OF INTERPRETATIONS IN THE 27 
^CANCER" PATIENTS (PHASE I) . 
A B 
Radiologist 
C D E F G H I J 
Normal 0 1 2 1 2 2 3 1 4 6 
Abnormal- 
Benign/ 
Indeter¬ 
minate 4 6 5 6 6 6 8 11 11 11 
Abnormal- 
Suspicious 
for Cancer 23 20 20 20 19 19 16 15 12 10 
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TABLE 10. ACCURACY OF DIAGNOSTIC INTERPRETATION AND PERTINENCE 
OF MANAGEMENT RECOMMENDATIONS [PHASE I], 
It 
MANAGEMENT RECOMMENDATIONS 
DIAGNOSTIC INTERPRETATION^ 
% of Patients with Immediate 
Work-UD Recommended^ 
RADIOL- 
06IST Sensitivity(%) 
(N=27) 
Specificity(%) 
(N=123) 
Cancer 
Patients 
(N=27) 
Non-Cancer 
Patients 
(N=123) 
A 85 93 93 57 
B 74 94 93 65 
C 74 94 96 40 
D 74 85 96 64 
E 70 87 89 41 
F 70 93 85 44 
G 59 94 78 30 
H 56 93 81 38 
I 44 99 85 45 
J 37 97 74 11 
1. For calculating sensitivity and specificity, partitions were 
'Abnormal-Suspicious for Cancer' category vs 'Abnormal-Indeterminate', 
'Abnormal-Probably Benign', and 'Normal' categories. 
'Immediate work-up' defined as a recommendation to obtain additional 
mammogram views, ultrasound, and /or biopsy. 
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TABLE 11. ACCURACY OF DIAGNOSTIC INTERPRETATION AND PERTINENCE 
OF MANAGEMENT RECOMMENDATIONS (PHASE II) . 
MANAGEMENT RECOMMENDATI0N8 
DIAGNOSTIC INTERPRETATION^ 
% Of Patlonts with Immediate 
Work-UD Recommended^ 
RADIOL- 
06I8T Sensitivity(%) 
(N=27) 
Specificity(%) 
(N=123) 
Cancer 
Patients 
(N=27) 
Non-Cancer 
Patients 
(N=123) 
A 74 93 100 72 
B 70 98 96 48 
C 81 87 85 38 
D 85 81 96 53 
E 67 85 78 36 
F 70 94 85 36 
G 67 100 89 33 
H 59 89 85 38 
I 56 97 85 41 
J 30 99 70 10 
1. For calculating sensitivity and specificity, partitions were 
'Abnormal-Suspicious for Cancer' category vs 'Abnormal- 
Indeterminate', Abnormal-Probably Benign', and 'Normal' categories. 
'Immediate work-up' defined as a recommendation to obtain additional 
mammogram views, ultrasound, and /or biopsy. 
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APPENDIX 1 
For office use onlv 
immOGRAM: PATIENT HISTORY FORM (1-3) _ 
(A-5) _ 
(BI^PP/^USAL STATUS: Pre _ Post _ (6) _ 
u.<?T01?T OF BREAST BIOPSY: Yes No .. (7) _ 
Tears since biopsy _ _ (8-9) _ 
(10) _ 
(11-12) _ 
PREVIOUS BT STORY OF CANCER Yes No . ... (13) _ 
EAMTT.Y HISTORY OF BREAST CANCER*. Yes No (lA) _ 
PaI va» (15) _ 
Age of individual when cancer was found - (16-17) _ 
(18) _ ■ 
(19-20) _ 
CURRENT ESTROGEN USE: Vaq No Uncertain 
(21) _ 
Years of estrogen _ (22-23) _ 
5IPN5 SYIIPTOMS: 
Right_ Left- (2A) _ Lmp:. 
Nipple change: Right_ Left- 
(25) _ 
Nipple discharge: Right_ Left- 
(26) _ 
Fain: Right_ Left- 
(27) _ 
Skin change: Right_ Left- 
(28) _ 
(29) _ 
(30) _ 
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APPENDIX li 
PATIENT HISTORY FORM: DEFINITIONS AND CODING 
The definitions below clarify the terms used on the patient history form. 
Each definition is followed by numbers (in parentheses) and an abbreviated 
term used for computer coding. 
MAMMOGRAM: mammograms given randomly assigned number, 1-150, for 
Phase I and 151 - 305 for Phase II 
n-31 MAMMO 
AGE: age of patient at 1987 mammogram 
(4.51 AGE 
MENOPAUSAL STATUS: (Pre) - pre-menopausal in 1987 or ^ 50 years of age 
with history of hysterectomy and one or both ovaries remaining 
(Post) - post-menopausal in 1987 or > 50 years of 
age with a history of hysterectomy, regardless of whether one or both ovaries 
remained 
(6) MENOPA 
0: Pre 
1: Post 
HISTORY OF BREAST BIOPSY: (Yes/No) - history of breast biopsy prior to 
1987 mammogram (positive response included location information such as 
right, left or bilateral); with more than one biopsy, location information provided 
for each procedure 
(71 HXBX1 
0: No 
1: Right 
2: Left 
3: Bilat 
YEARS SINCE BIOPSY: number of years, prior to 1987, that biopsy was 
performed 
(8.91 BXYRS1 
00: Not Applicable 
99: Not Certain 
HISTORY OF BREAST BIOPSY: (Yes/No) - repeated for second biopsy, if 
applicable 
(101 HXBX2 
0: No 
1: Right 
2: Left 
3: Bilat 
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YEARS SINCE BIOPSY: information repeated for second biopsy, if applicable 
(11.12^ BXYRS2 
00: Not Applicable 
99: Not Certain 
PREVIOUS HISTORY OF CANCER: (Yes/No) - history of cancer (other than 
breast cancer 
nS) HXCA 
0: No 
1: Cervical 
2: Parotid Tumor 
3: Squamous Skin 
4: Uterine 
5: Thyroid 
6: Basal Cell Lip 
7: Melanoma 
FAMILY HISTORY OF BREAST CANCER: (Yes/No) - history of breast cancer in 
patient’s family 
(14) FMH 
0: No 
1: Yes 
FIRST DEGREE RELATIVE: specific relative afflicted; any other relative 
categorized as ’other’; if just ’aunt’, relative was coded as ’maternal aunt’ 
(15) REL1 
1: Mother 
2: Sister 
3: Maternal Grandmother 
4: Paternal Grandmother 
5: Maternal Aunt 
6: Paternal Aunt 
7: Daughter 
8: Other 
0: Not Applicable 
AGE OF INDIVIDUAL WHEN CANCER WAS FOUND: age of relative when 
cancer was diagnosed 
(16.17) RELAGE1 
00: Not Applicable 
99: Uncertain 
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(18) REi-2 (Information repeated for second relative) 
(19,20) RELAGE2 (Information repeated for second relative) 
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CURRENT ESTROGEN USE: (Yes/No/Uncertain) - includes use of estrogen, 
premarin, progesterone, and birth control medication 
(21) ESTROGEN 
0: No 
1: Yes 
9: Uncertain 
YEARS OF ESTROGEN: length of time, in years, of estrogen use prior to 1987 
(22.23) ESTYRS 
00: Not Applicable 
99: Uncertain 
SIGNS AND SYMPTOMS: positive findings, by patient report, for breast lump, 
nipple change, nipple discharge, pain, and skin change; category was further 
defined by left or right breast 
(24) LUMP 
1: Right 
2: Left 
3: Bilat 
0: Not Applicable 
(25) NIPPLE CHANGE 
1 Right 
2 Left 
3 Bilat 
0 Not Applicable 
(26) NIPPLE DISCHARGE 
1 Right 
2 Left 
3 Bilat 
0 Not Applicable 
(27) PAIN 
1 Right 
2 Left 
3 Bilat 
0 Not Applicable 
(28) SKIN CHANGE 
1 Right 
2 Left 
3 Bilat 
0 Not Applicable 
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PICTURE: graphic picture and/or comments used, in some cases, to denote 
specific location of biopsy scar(s), lump(s), skin change(s), etc.; picture 
completed by mammography technologist at time of 1987 mammogram; 
additional comments which were written by the technologist were copied 
verbatim 
(291 PICTURE 
0: No 
1: Yes 
CANCER PRESENT: used for coding purposes only 
(301 CANCER 
0: No 
1: Yes 
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APPENDIX III 
INTERPRETATION CHECK LIST 
Mammogram 
Radiologist _ 
NO SIGNIFICANT ABNORMALITY 
ABNORMAL FINDING 
I. Mass: 
_ Probably benign 
 Intermediate concern 
_ Suspicious for malignancy 
II. Calcifications: 
_ Probably benign 
 Intermediate concern 
_ Suspicious for malignancy 
III. Focal Asymmetric Density: 
_ Probably benign 
 Intermediate concern 
_ Suspicious for malignancy 
IV. Architectural Distortion: 
_ Probably benign 
 Intermediate concern 
_ Suspicious for malignancy 
V. Other Findings: 
_ Skin retraction 
 Nipple retraction 
_ Skin thickening 
 Trabecular thickening 
VI. Other_ 
VII. Location of Abnormality 
_Left _Right 
_Left _Right 
ABNORMAL FINDING - PROBABLY BENIGN 
ABNORMAL FINDING - INDETERMINATE 
ABNORMAL FINDING - SUSPICIOUS FOR MALIGNANCY 
RECOMMENDATIONS FOR FOLLOW-UP 
_ Physical exam _ Age appropriate follow-up 
 Ultrasound exam  Repeat Mammogram_mths 
____ Additional X-ray views 
at this time 
_  Biopsy 
O’clock 
O’clock 
Skin lesion 
Axiliary adenopathy 
Solitary dilated duct/ 
tubular density 
For 0«b* 
Um Only 
(1)_ 
(2-4) _ 
(5-6) _ 
(7) _ 
(8) _ 
(9) _ 
(10)_ 
(11)_ 
(12)_ 
(13) _ 
(14) _ 
(15) _ 
(16) _ 
(17) _ 
(18) _ 
(19) _ 
(20) _ 
(21.22)_ 
(23)_ 
(24. 25)_ 
(26)_ 
(27) _ 
(28) _ 
(29) _ 
(30) _ 
(31) _ 
(32,33)_ 
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APPENDIX IV 
INTERPRETATION CHECK LIST: 
DEFINITIONS AND CODING 
The terms below correspond to the Interpretation Check List Form. The 
numbers in parentheses, as well as the abbreviated term, were used for 
computer coding. 
m PHASE-Phase# 
0: 1987 Reading 
1: Phase I 
2: Phase 2 
(2-4) MAMMO-Mammoqram 
#001 to #150 or #151 to #305 
(5-6) MD-Radioloaist # 
A - J: 10 study radiologists 
Z: a 1987 radiologist 
(7) HIST-Clinical History 
0: Non-Present 
1: Present 
2: False History Present 
(8) FIND-Findinq 
0: No - No Significant Abnormality 
1: Yes - Abnormal Finding - Probably Benign 
2: Yes - Abnormal Finding - Indeterminate 
3: Yes - Abnormal Finding - Suspicious For Malignancy 
9: Unknown - Poor Quality Film 
f91 MASS-Mass 
0: No 
1: Probably Benign 
2: Intermediate Concern 
3: Suspicious For Malignancy 
()0) CALC-Calcifications 
0: No 
1: Probably Benign 
2: Intermediate Concern 
3: Suspicious For Malignancy 
n 1) FOCAD Focal Asymmetric Density 
0: No 
1: Probably Benign 
2: Intermediate Concern 
3: Suspicious For Malignancy 
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(12) ARCHDI-Architectural Distortion 
m. 
0: No 
1: Probably Benign 
2: Internnediate Concern 
3: Suspicious For Malignancy 
SKINRE-Skin Retraction 
0: No 
1: Yes 
m. NIPPRE-Nioole Retraction 
0: No 
1: Yes 
(15) SKINTH-Skin Thickenino 
0: No 
1: Yes 
im. TRABTH-Trabecular Thickenino 
0: No 
1: Yes 
(17) SKINLE-Skin Lesion 
0; No 
1: Yes 
(18) AXILAD-Axillarv Adenooathv 
0: No 
1: Yes 
(19) DUCT-Solitarv Dilated Duct/Tubular Density 
0: No 
1: Yes 
(20) SIDEI-Side of Abnormalitv 
0: No Abnormality 
1: Right 
2: Left 
3: Bilateral 
(21,22) LOCAT1-Location of Abnormalitv 
00: No Abnormality 
1-12 o’clock 
13: Retroareolar 
14: Central 
15: Axilla 
16: Diffuse/Scattered 
17: Other (10=UOQ, 8=LOQ, 4= 
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(23) SIDE2-Side of Second Abnormality 
0: No 
1: Right 
2: Left 
3: Bilateral 
(24,25) LOCAT2-Location of Second Abnormality 
00: No Abnormality 
1 -12_o’clock 
13: Retroareolar 
14: Central 
15: Axilla 
16: Diffuse/Scattered 
17: Other (10=UOQ, 8=LOQ, 4=LIQ. 2=UIQ) 
(26) PHYSEX-Phvsical Exam Suggested 
0: No 
1: Yes 
(27) ULTRAS-Ultrasound Exam Suggested 
0: No 
1: Yes 
(28) ADDVWS-Additional Views Suggested At This Time 
0: No 
1: Yes 
(29) BIOPSY-Biopsv 
0: No 
1: Yes 
2: If Other Recommendations are Positive 
(30) AGEFU-Aae Appropriate Follow-up 
0: No 
1: Yes 
(31) REPEAT-Reoeat Mammogram 
0: No 
1: Yes 
(32.33) MONTHS-Months Until Repeat MamrTX)gram 
00: No Repeat Mammogram 
INTERPRETATION CHECK LIST 
CODING INSTRUCTIONS 
The Interpretation Check List was coded according to notations made 
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by the radiologists. Clarifications of some of the coding complexities follow; 
1. Within any sub-category, if two abnormalities were noted, only the 
most suspicious interpretation was coded. If two abnormalities were 
noted in different sub-categories, both were coded. 
2. In coding the exact location of the abnormality(ies), reference to a 
clock face was used. If the location was not designated by 
’_o’clock’, but was designated by quadrant, the quadrant was 
translated to the appropriate ’o’clock’ location (2, 4, 8, or 10 o’clock) 
for each breast. 
3. If an ’o’clock’ notation was designated (e.g., 7:30 or 2 - 3 o’clock), 
this was always coded by the lower o’clock number. 
4. If the location of the abnormality was designated by a narrative, the 
following categories were used in coding: retroareolar, central, 
axillary, diffuse/scattered. Any other narrative was coded as ’other’. 
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APPENDIX V 
RADIOLOGISTS’ INSTRUCTIONS FOR INTERPRETATION CHECK LIST 
Thank you for participating in this study of mammography. 
Below, please find instructions for the interpretation check list which will be 
used to document your findings. Please complete one check list for each 
case. Only four views will be available for this study. A clinical history is 
available for only some of the cases. When a breast biopsy is noted in the 
clinical history, the results were negative. 
Please interpret these mammogram cases as you would in your regular 
clinical setting. 
1. The information in the top right corner of the checklist has been 
completed by us and should include: 
i. The identification number of the case being interpreted. 
ii. The personal identification letter assigned to you. 
2. Only four major categories are available. They are as follows; 
’No Significant Abnormality’ 
’Abnormal Finding - Probably Benign’ 
’Abnormal Finding - Indeterminate’ 
’Abnormal Finding - Suspicious for Malignancy’ 
Because these four categories are mutually exclusive, please check 
only one category for each use. For this study, fibrocystic disease 
falls under the category of ’No Significant Abnormality’. The 
category listed as ’Abnormal Finding - Indeterminate’ should only be 
used if it is impossible for you to assign any of the other categories 
without additional information. The category ’Abnormal Finding - 
Suspicious for Malignancy’ should only be used when 
recommendations for a biopsy are in order. 
3. To ensure consistency within this study, the following brief 
definitions for ’Abnormal Findings’ are provided below; 
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I. MASS: A space-occupying lesion seen in two different 
projections. If a potential mass is seen in only a single 
projection, it should be called a ’DENSITY’ until its three- 
dimensionality is confirmed. 
II. CALCIFICATIONS: Any calcium deposit that could potentially 
represent a malignancy should be noted. 
III. FOCAL ASYMMETRIC DENSITY: This is a density that cannot 
be accurately described using the other shapes. It is visible as 
asymmetry of tissue density. It could represent an island of 
normal breast, but its lack of specific benign characteristics may 
warrant further evaluation. 
IV. ARCHITECTURAL DISTORTION: The normal architecture is 
distorted with no definite mass visible. This includes spiculation 
radiating from a point and focal retraction or distortion of the 
edge of the parenchyma. 
V. OTHER FINDINGS: 
SKIN RETRACTION: The skin is pulled in abnormally. 
NIPPLE RETRACTION: The nipple is pulled in or inverted 
SKIN THICKENING: This may be focal or diffuse. 
TRABECULAR THICKENING: This is a thickening of the 
fibrous septae of the breast. 
SKIN LESION: Noted when it projects over the breast in two 
views. 
AXILLARY ADENOPATHY: Enlarged axillary lymph nodes, 
apparently replaced by non-fatty tissue. 
SOLITARY DILATED DUCT/TUBULAR DENSITY: A tubular or 
branching structure that likely represents a dilated or 
otherwise enlarged duct. 
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VI. OTHER: this category does not have to be filled out. It may be used 
at your discretion, if you would like to make note of anything. We 
would be happy to return these forms to you at the end of the study 
and you may find them helpful when reviewing our final study results. 
4. If your interpretation includes more than one abnormal finding, 
please indicate all on the check list. When marking the presence of 
the most suspicious abnormal finding(s). mark a ’1’ next to the 
finding(s) and state the corresponding location of the most 
suspicious finding under the first part of ’VII. Location of 
Abnormality.’ Mark a ’2’ next to any finding(s) that is of lesser 
suspicion and state the corresponding location under the second 
part of ’VII. Location of Abnormality’. Place an ’X’ next to any 
additional abnormal finding(s) noted. The location of the (X) 
finding(s) can not be designated unless you choose to do so under 
the ’VI. Other’ section. (Although more than one abnormal finding 
may be noted on this check list form, please choose only one major 
category for your final interpretation.) 
5. At the bottom of the checklist, place a mark next to any 
’Recommendations for Follow-Up’ you wish to make. Place a mark 
next to the stated recommendation only if you want to recommend it 
for specific follow-up. Please recommend at least one form of 
follow-up. You may recommend more than one type of follow-up if 
you feel it is warranted (e.g. both a physical exam and an 
ultrasound). Mark only one choice for timing of mammographic 
follow-up (’Age Appropriate Follow-up’ or ’Repeat Mammogram in 
_Months’). List the time, in months, suggested for repeated 
mammogram if you choose that recommendation. 
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APPENDIX VI 
TELEPHONE SURVEY OF PARTICIPATING RADIOLOGISTS 
1. Do you consider yourself an expert in mammography? 
Yes No_ 
2. Did you recognize any of the films in the second phase? 
Yes_ No_ 
If yes to above; A) How many? 
1%-20% / 21%-40% / 41%-60% / 61%-80% / 81%-100% 
B) In how many films did you remember what 
your initial reading was in Phase I ? 
0% / 1%-20% / 21%-40% /41%-60% / 61%-80% / 81%-100% 
3. Since it would be expected that radiologists may vary in their interpretation of 
mammograms, in what percentage of cases is this variability clinically 
important? 
0% / 1%-20% / 21%-40% / 41%-60% / 61%-80% / 81%-100% 
4. Did you give these mammograms the same consideration as in your clinical 
practice? 
Yes No Other 
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APPENDIX VII 
TRANSCRIPT: CONFERENCE OF PARTICIPATING RADIOLOGISTS 
INTRODUCTION 
The Consensus Conference was attended by eight of the ten 
participating radiologists and all five investigators at the conclusion of Phase II 
testing. A brief review of the research design and preliminary data was 
presented. Six mammograms which showed great variability in interpretation 
were discussed. The radiologists’ comments regarding the variability can be 
summarized in four categories: 
1) Abnormalities were simply missed by some radiologists 
2) Disagreement was often present as to whether a visual appearance 
fit criteria for certain diagnoses 
3) Radiologists were asked to categorize diagnoses without immediate 
follow-up information 
4) Different thresholds were used when making the diagnoses and 
recommendations. 
The six mammograms discussed by Conference participants are 
noted below. Following each mammogram ’heading’, in parentheses, is the 
subsequent cancer outcome of each case. (The radiologists were not informed 
of this result until the end of each discussion.) For each case, the variability 
among the ten radiologists in interpretations and management 
recommendations is also shown. For purposes of confidentiality, the 
radiologists are noted by number in the order that they spoke. 
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Mammogram I (’NO CANCER’) 
INTERPRETATIONS# 
 RADIOLOGISTS 
Normal 
Abnormal-probably benign 
Indeterminate 
Abnormal-suspicious for cancer 
4 
2 
3 
MANAGEMENT 
RECOMMENDATIONS #RADIOLOGISTS 
Age-appropriate follow-up 
Repeat Mammogram < 6 mos. 
Add’I X-ray views now 
Ultrasound 
Biopsy 
3 
1 
1 
0 
2 
RAD. #1 
"what bothered my eye was the asymmetry in the periareola area...The 
thickening in the left nipple caught my eye...when I look at a mammogram I 
look for some degree of symmetry...In my practice I would have asked my 
technologist about the left nipple...Maybe it is technical but, when I read these 
mammos I didn’t worry about technique. I figured if you presented them to me 
you already dealt with the technique part...I was worried...! read it as malignant. 
I thought it was Paget’s, frankly...! didn’t see anything in the right breast that 
bothered me. I thought there were benign calcifications." 
RAD. #2 
"I called this normal and I was fairly shocked because when you put the film up 
I said, ’Gee, look at that’...I didn’t see it...This is the thing that you hope 
doesn’t happen to you in your practice.’ "One thing has changed since 
1987...some people say that if you can see the skin on a mammogram, then it 
is an improperly exposed mammogram. I actually have stopped looking at the 
skin or nipple anymore. In this case, I would certainly examine the nipple, 
bring her back for some compressions...and mention to her physician, 'What is 
going on with this nipple?’" 
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RAD. #3 
There is some range of asymmetry that is tolerable...This passes my threshold 
for asymmetry." 
RAD. #4 
"I made no comment about that as well. I dwelled on the calcifications...! can't 
tell you whether I didn’t notice it or I dismissed it as within the range of 
variability that is O.K. around the areola. Elsewhere in the breast I would 
consider that significant, but the areola is the one area where there can be 
both much more thickening and asymmetry. I’m not sure what you do about it 
other than making a punch biopsy anyway. If you think that is abnormal, then I 
don’t think I would follow it...you’d either call it normal or punch biopsy the 
skin. Those are the only choices." 
RAD. #5 (Discussing breast calcifications) 
"I thought some of these were irregular. They branch, are...fat in one part and 
skinny in another...! was worried about them. I must say I am a Homer 
advocate. He really believes that calcifications cannot be categorized. We’ve 
seen in our practice, more than once, calcifications that are punctate, should 
be benign, and are malignant...It’s a few of them, it’s not all of them...l don’t 
know how many you have to have before you worry about them. I wouldn’t 
call these benign, I know that. I wouldn’t dismiss them...The other problem I 
had with many of these cases, and when I did the first set I wasn’t really sure 
what to do...I would almost always get mag views...except for a small number 
of these which are grossly malignant, my next step would have been to get 
mag views; I wouldn’t have biopsied many at all." 
DISCUSSION LEADER #2 
"What about someone who thought these calcifications were grossly benign?" 
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RAD. #1 
"Now that I look at them, I am a little bit more concerned about them, but I 
think they didn’t really bother me that much because I saw similar calcifications 
in the right breast...I thought they were all sort of secretory calcifications...! 
wrote them off. I didn’t even mention them." 
RAD. #6 
"I agree." 
RAD. #4 
"The ones that are branching are two overlapping secretory calcifications." 
DISCUSSION LEADER # 1 
"If I said ’O.K., picture a mammogram that has this,’ and describe just what you 
said, calcifications that are branching, irregularly shaped, everybody would 
agree that those are suspicious. The question is when you look at this, some 
people come up with, ’Gee, these fit those criteria and therefore are 
suspicious,’ and others say, ’these do not fit those criteria and are therefore not 
suspicious.’" 
DISCUSSION LEADER #2 
"The disagreement here is not on the criterion...but whether that particular 
visual appearance fits the designation of pleomorphic, etc..." 
RAD. #9 
"I pushed for additional views and to bring her back in three months...! pushed 
because there was certainly asymmetry between the appearance of both 
breasts, and the periareola skin thickening in the left breast was worrisome, but 
indeterminate in my eyes; that is why...I wanted more films right now and plus 
bring her back in three months." 
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MAMMOGRAM II (CANCER) 
INTERPRETATIONS # RADIOLOGISTS 
Normal 
Abnormal-probably benign 
Indeterminate 
0 
2 
5 
3 Abnormal-suspicious for cancer 
MANAGEMENT 
RECOMMENDATIONS # RADIOLOGISTS 
Age-appropriate follow-up 
Repeat mammograms < 6 mos. 
Add’l x-rays views now 
Ultrasound 
Biopsy 
0 
6 
7 
2 
DISCUSSION LEADER #1 
"This is a case we picked because everyone agreed on the finding; unlike the 
last case where some didn’t mention it, other people thought calcifications, 
others density. Everybody agreed what was the abnormality in this case." 
RAD. #1 
"I think this is a good example of the kind of case in which we are being 
artificially forced to make checks on a form, which is not necessarily the way 
most, if not all of us, would practice. I think we all see what it is, probably all 
of us would want to get spot compression views of it, then probably ultrasound 
it, and then make a recommendation...so, I checked ultrasound...additional 
views, and I made an arrow with a question mark to biopsy." (Group Agreement) 
DISCUSSION LEADER #2 
"Is there anything else in the film that anyone wants to comment on?" 
RAD. #2 
"When I took the magnifying glass, I was really impressed that when you mag 
that thing it is irregular. It bothered me very much...l read it as suspicious....If 
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that thing was 5 mm or less, I might sit on it...but this thing is big, a centimeter 
or bigger. Its got hazy margins...slight increase in trabecular pattern in that 
area. It caught my eye and everything pointed toward a malignant 
process...Just because it is round doesn’t write off malignant." 
RAD. #1 
"I don’t see smooth margins, but I’ve seen countless cases of things that I’ve 
needled and when the specimen comes out it looks lOx smoother than on the 
mag view...so, I won’t be shocked if it does have smooth margins." 
RAD. #3 
"I thought from your instructions that you wanted me to say this is malignant or 
benign. That is not the way I conduct my mammography practice. In my 
practice, if something is wrong here, I have to get more information. I was 
extremely uncomfortable the first 50 cases thinking...on the basis of four films 
they want me to say this is probably benign or...so, after the first 50 cases, I 
was so uncomfortable...! said...’I’m going to do it my way.’" (Group Agreement) 
RAD #3 
"I wanted to put to the referring physician a big something. So, I put 
suspicious. I checked physical exam, ultrasound, additional x-rays and biopsy. 
I have seen too many round shadows that may look benign, but just don’t turn 
out to be...A solitary round mass in a woman’s breast; you do everything you 
can to prove it one way or the other." 
RAD. #4 
"The important thing about this case is that...I think everybody said to do 
something more." 
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DISCUSSION LEADER #1 
"None of the radiologists in this room disagree...the problem is with the artificial 
categorization. The reason why I wanted to show this case is because...! think 
these are basically the same readings, but if you look at the numbers, it looks 
different." 
MAMMOGRAM III (CANCER) 
INTERPRETATIONS_# RADIOLOGISTS 
Normal 1 
Abnormal-probably benign 7 
Indeterminate 2 
Abnormal-suspicious for cancer 0 
MANAGEMENT 
RECOMMENDATIONS_# RADIOLOGISTS 
Age-appropriate follow-up 1 
Repeat mammograms j< 6 mos. 5 
Add’l x-rays views now 4 
Ultrasound 6 
Biopsy 0 
RAD.#1 
"You’ve got some calcifications, a nodule there, a nodule there. You’ve got 
multiple findings and this is the kind of thing where I usually recommend 
asymptomatic follow-up in six months...! don’t know what she was like six 
months before...let the garden grow, if one of them is a cancer it is going to 
get bigger...and maybe we might find it in six months. If you say it is 
abnormal, then are you going to take that one out and that one out? I usually 
put this in a follow-up category." 
RAD. #2 
"I wrote the left one off as benign. I didn’t want to run up a big bill on this 
lady...I thought I could write that one off as very well circumscribed, but 
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recommended follow-up in six months. I was more aggressive on the right, 
primarily because of the scalloped margins and...the density was certainly 
larger than 1 cm. The calcifications I wrote off. I recommended ultrasound 
and said if that ultrasound turns out to be solid then I wanted that 
removed...Anything more than 8 mm and still well-circumscribed I still may 
remove it..that is something I’ve just developed through the years. Why I 
choose 8 mm? Well, I don’t know..I think Kopans uses it." 
RAD. #3 
"I felt fairly clear about the left breast being reasonably benign...but on the right 
breast, I felt that there were some margins...! couldn’t clear them completely. 
There was some superposition of tissue and I definitely needed some 
additional views...I go with anything greater than 8-10 mm in diameter is 
definitely going to need either mag views or an ultrasound...sometimes I really 
don’t care what the margins look like at all, I don’t care if they are blurred, I 
don’t care if they are circumscribed...I’m not using a clear size criteria either. If 
I can see a complete peripheral halo that is the only time I feel uncomfortable 
saying that it is probably benign. Sometimes you’ve got to do something more 
and I think doing an ultrasound or additional views are going to help you with 
that...I didn’t write down follow-up, but now, in retrospect, I would get some 
closer follow-up." 
DISCUSSION LEADER #1 
"I think what is interesting about this case is that the readings were pretty 
uniform. There were seven ’abnormal-probably benign’; but people described 
completely different things." 
RAD. #2 
"There were times I could have given you three or four masses on this 
thing..but I said, ’O.K., I’ll talk about two here.’" (Group agreement....after being 
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RAD.#4 
"I bet you even the people who said probably benign, but wanted to do a 
work-up are probably not going to be so shocked. I think probably benign 
means 5-10% of them are going to be cancers, but still we want to look for that 
percentage...I get the sense that we are all on the same wavelength. If you 
thought there was a 30-40% chance of cancer you might have it ’indeterminate’ 
or ’suspicious for malignancy’. But, a 10% chance still is enough to do 
something._ 
RAD. #3 
"I’m prepared to be wrong if I recommend biopsy a lot of the time. It doesn’t 
bother me if something comes back normal. But, there are some things I don’t 
biopsy at all because they are not indeterminate." 
DISCUSSION LEADER #1 
"We have a 25-30% biopsy rate (at Yale). If you have a 10% positive biopsy 
rate, your surgeons aren’t going to be too happy with your readings." 
MAMMOGRAM IV ( CANCER’) 
INTERPRETATIONS_# RADIOLOGISTS 
Normal 5 
Abnormal-probably benign 2 
Indeterminate 1 
Abnormal-suspicious for cancer 2 
MANAGEMENT 
RECOMMENDATIONS_# RADIOLOGISTS 
Age-appropriate follow-up 5 
Repeat mammograms <6 mos. 0 
Add’l x-rays views now 5 
Ultrasound 0 
Biopsy 2 
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DISCUSSION LEADER #1 
"Some people thought calcifications, some thought asymmetric density in the 
right breast. One person thought thickening of the parenchyma...so this really 
was a case that had a lot of variability." 
RAD. #1 
"I read this as normal and as I sit in the back of the room I am a little bothered 
by the retroglandular tissue of that left breast." 
RAD. #2 
"I thought this was suspicious because of the calcifications." 
DISCUSSION LEADER #2 
"Someone who called this ’normal’, do those calcifications turn you on?" 
RAD. #3 
"They are not clustered to my eye, they have varying sizes...they don’t maintain 
a strictly segmental distribution. They didn’t get my threshold. We all have 
different thresholds." 
[Part of discussion on Mammogram 'D' and was missed when the tape was being 
turned over] 
MAMMOGRAM V (’NO CANCER’) 
INTERPRETATIONS_# RADIOLOGISTS 
Normal 1 
Abnormal-probably benign 3 
Indeterminate 4 
Abnormal-suspicious for cancer 2 
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MANAGEMENT 
RECOMMENDATIONS # RADIOLOGISTS 
Age-appropriate follow-up 
Repeat mammograms < 6 mos. 
Add’I x-rays views now 
Ultrasound 
Biopsy 
4 
7 
0 
0 
RAD. #1 
"I saw a mass on the right. I saw it on one view, but I saw it on one view fairly 
well...maybe I didn’t have my coffee that day...Now, I’m not so concerned...! 
think it was right in here. It looked like I saw something that was marginated." 
DISCUSSION LEADER #1 
"Why is it that some people see masses and others don’t?" 
RAD. #1 
"It is purely perceptual. I can’t teach you to perceive something the way I 
perceive it...that is one thing that you can’t be taught." 
RAD.#2 
"Some of us may have sat down and read these 150 mammograms in three 
batches of 50, sat down, read 50, got up, sat down...some of us only read two 
to three at a time." 
DISCUSSION LEADER #2 
"What is on that film is on that film...it is then a matter of how we perceive that. 
Now, there are sometimes when somebody will say to me, ’it’s a rorschach test 
and it shows a dancing ballerina on Hollywood Bowl’ and somebody else says. 
’I don’t see it!’ That is an instance where you are seeing the same thing but 
you just don’t see the certain forms." 
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RAD. #3 
"This is one of the problems I had with the way the study was set up...I agree 
there are calcifications on both sides and I want other views. Then somebody 
asks me what category to put it into. It doesn’t really matter in my mind. I 
don’t care if you call it ’suspicious for malignancy’. I want additional views 
before I suggest a biopsy." 
MAMMOGRAM VI (’NO CANCER’) 
INTERPRETATIONS_# RADIOLOGISTS 
Normal 0 
Abnormal-probably benign 3 
Indeterminate 3 
Abnormal-suspicious for cancer 4 
MANAGEMENT 
RECOMMENDATIONS_# RADIOLOGISTS 
Age-appropriate follow-up 1 
Repeat mammograms :< 6 mos. 0 
Add’I x-rays views now 0 
Ultrasound 0 
Biopsy 3 
DISCUSSION LEADER #1 
"This is a cute case because everyone saw the same finding which was skin 
retraction and this ugly looking area. Phase I readings...with no clinical history 
was ’abnormal-probably benign’, three people. Three people said it was 
’indeterminate’ and four said it was ’suspicious’. It turns out she had a 
biopsy...and when you got the history the second time around, everyone read 
it as either ’abnormal-probably benign’, related to the biopsy...or completely 
’normal’. 
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